Search Within

Howard Scher

  1. "Computational Oncology Service"
Formats
  1. Journal Article (25)
  2. Meeting Abstract (21)
  3. Research Letter (1)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (47)
  2. Computational Oncology Service (47)
  3. Department of Medicine (47)
  4. Epidemiology and Biostatistics (47)
  5. GSK Faculty (47)
  6. Genitourinary Oncology Service (47)

More Groups

People
  1. Nikolaus Schultz (42)
  2. Wassim Abida (29)
  3. David Solit (26)
  4. Michael Berger (21)
  5. Michael Morris (16)
  6. Anuradha Gopalan (15)

More People

Years
  1. 2024 (2)
  2. 2023 (2)
  3. 2022 (4)
  4. 2020 (8)
  5. 2019 (6)
  6. 2018 (6)

More Years

Publications
  1. Journal of Clinical Oncology (12)
  2. Cancer Research (5)
  3. Clinical Cancer Research (4)
  4. European Urology (3)
  5. JCO Precision Oncology (3)
  6. Nature (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (15)
  2. American Association for Cancer Research (10)
  3. Nature Publishing Group (8)
  4. Elsevier Science, Inc. (3)
  5. American Society of Hematology (2)
  6. Cell Press (2)

More Publishers

Results (47)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Automated real-world data integration improves cancer outcome prediction
    Journal Article

    Jee, J.; Fong, C.; Pichotta, K.; Tran, T. N.; Luthra, A.; Waters, M.; Fu, C.; Altoe, M.; Liu, S. Y.; Maron, S. B.; more...
    Nature (2024)

    Fulltext@MSK | Save
  • Microsatellite instability, tumor mutational burden, and response to immune checkpoint blockade in patients with prostate cancer
    Journal Article

    Lenis, A. T.; Ravichandran, V.; Brown, S.; Alam, S. M.; Katims, A.; Truong, H.; Reisz, P. A.; Vasselman, S.; Nweji, B.; Autio, K. A.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Impact of PARP inhibitor and platinum therapy on clonal hematopoiesis
    Meeting Abstract

    Baeten, J. T.; Chan, I. C. C.; Moukarzel, L.; Carter, A. C.; Patel, M.; Stopsack, K. H.; Pharoah, P.; Brenton, J.; Li, B. T.; Abida, W.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Analysis of BRCA2 copy number loss and genomic instability in circulating tumor cells from patients with metastatic castration-resistant prostate cancer
    Journal Article

    Barnett, E. S.; Schultz, N.; Stopsack, K. H.; Lam, E. T.; Arfe, A.; Lee, J.; Zhao, J. L.; Schonhoft, J. D.; Carbone, E. A.; Keegan, N. M.; more...
    European Urology (2023)

    Fulltext@MSK | Save
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
    Journal Article

    Jee, J.; Lebow, E. S.; Yeh, R.; Das, J. P.; Namakydoust, A.; Paik, P. K.; Chaft, J. E.; Jayakumaran, G.; Brannon, A. R.; Benayed, R.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • The impact of PIK3R1 mutations and insulin-PI3K-glycolytic pathway regulation in prostate cancer
    Journal Article

    Chakraborty, G.; Nandakumar, S.; Hirani, R.; Nguyen, B.; Stopsack, K. H.; Kreitzer, C.; Rajanala, S. H.; Ghale, R.; Mazzu, Y. Z.; Pillarsetty, N. V. K.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Optimal strategy and benefit of pulsed therapy depend on tumor heterogeneity and aggressiveness at time of treatment initiation
    Journal Article

    Mathur, D.; Taylor, B. P.; Chatila, W. K.; Scher, H. I.; Schultz, N.; Razavi, P.; Xavier, J. B.
    Molecular Cancer Therapeutics (2022)

    Fulltext@MSK | Save
  • Differences in prostate cancer genomes by self-reported race: Contributions of genetic ancestry, modifiable cancer risk factors, and clinical factors
    Journal Article

    Stopsack, K. H.; Nandakumar, S.; Arora, K.; Nguyen, B.; Vasselman, S. E.; Nweji, B.; McBride, S. M.; Morris, M. J.; Rathkopf, D. E.; Slovin, S. F.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Oncologic therapy shapes the fitness landscape of clonal hematopoiesis
    Meeting Abstract

    Bolton, K. L.; Ptashkin, R. N.; Gao, T.; Braunstein, L.; Devlin, S. M.; Patel, M.; Berthon, A.; Syed, A.; Yabe, M.; Coombs, C.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • CDK12 alterations define a distinct molecular subtype of prostate cancers with unique genomic and clinical characteristics
    Meeting Abstract

    Nguyen, B.; Mota, J. M.; Nandakumar, S.; Stopsack, K. H.; Weg, E.; Rathkopf, D.; Morris, M. J.; Scher, H.; Kantoff, P. W.; Gopalan, A.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save